Yılmaz, SüleymanDemiraran, YavuzAkkan, NerminYaman, Hüseyinİskender, AbdülkadirGüçlü, EnderÖztürk, Özcan2020-04-302020-04-3020090165-5876https://doi.org/10.1016/j.ijporl.2009.05.006https://hdl.handle.net/20.500.12684/4991WOS: 000269224900007PubMed: 19500860Objective: To reduce the post-tonsillectomy morbidity by swab soaked with 5 ml levobupivacaine hydroclorur (25 mg/10 ml). Study design: A double-blind prospective randomized controlled clinical study. Methods: In this randomized double-blind study in group I (30 children, mean age 7.5 +/- 2.6) we tightly packed swab soaked with 5 ml levobupivacaine hydroclorur (25 mg/10 ml) and in group II (21 children, mean age 7.9 +/- 3.7) we used 5 ml saline swabs into each of the two tonsillar fossae after tonsillectomy for 5 min. We used McGrath's face scale to compare the two groups in respect of pain control. Results: There was statistically significant pain relieving effect in the levobupivacaine group in the first 24 h (p < 0.05). But after 24 h pain relieving effect of levobupivacaine was not significant (p > 0.05). We did not see any serious complications for both groups. Postoperative morbidity mean results (nausea, vomiting, fever, bleeding, halitosis and ear pain) were not statistically different between the two groups (P > 0.05). Conclusion: Topical levobupivacaine seems to be a safe and easy medication for postoperative pain control in pediatric tonsillectomy patients. (c) 2009 Elsevier Ireland Ltd. All rights reserved.en10.1016/j.ijporl.2009.05.006info:eu-repo/semantics/closedAccessLevobupivacaineTonsillectomyMcGrath's face scalePain relieving effectArticle73912081210WOS:000269224900007Q2Q3